Citigroup’s Allergan plc AGN.PRA Stock Holding History

Citigroup’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-99	Closed	-$58K	–	7816
2017 Q4	$58K	Sell	99 -390	-80%	-$252K	﹤0.01%	6076
2017 Q3	$361K	Buy	489 +390	+394%	+$324K	﹤0.01%	4437
2017 Q2	$86K	Hold	99	–	–	﹤0.01%	5466
2017 Q1	$84K	Buy	99 +6	+6%	+$4.97K	﹤0.01%	5338
2016 Q4	$71K	Buy	93 +20	+27%	+$15.1K	﹤0.01%	5979
2016 Q3	$60K	Hold	73	–	–	﹤0.01%	5554
2016 Q2	$61K	Sell	73 -43,425	-100%	-$36.3M	﹤0.01%	5447
2016 Q1	$40M	Buy	43,498 +42,051	+2,906%	+$40.2M	0.04%	358
2015 Q4	$1.49M	Sell	1,447 -4,553	-76%	-$4.57M	﹤0.01%	2728
2015 Q3	$5.66M	Sell	6,000 -8,413	-58%	-$8.77M	0.01%	1562
2015 Q2	$15M	Buy	+14,413	New	+$15.1M	0.01%	956

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Citigroup's AGN.PRA Position: Q1 2018 in Review

Citigroup sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 99 shares — an estimated $58K sold.

Citigroup first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $40M in Q1 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Citigroup reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Citigroup sold 99 Allergan plc shares in Q1 2018, an estimated $58K.
Citigroup first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
Citigroup's Allergan plc position peaked at $40M in Q1 2016.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Citigroup's 13F filing for Q1 2018, filed 11 May 2018.